The cutoff score had low specificity (31%).

When using the recommended MoCA cutoff score for impairment ( ≤ 26), the MoCA showed excellent sensitivity (100%) for identifying MCI or dementia.

MCI and Dementia (Goldstein et al, 2014 N=81 African Americans Normal Cognition (NC) n=38, mean age 65.8 (7.7), mean 13.4 (3.1) years of education 13.4 Mild Cognitive Impairment (MCI) n=38, mean age 71.9 (8.9), mean 10.9 (2.4) years of education Dementia n=27, mean age 70.5 (11.4), mean 11.7 (2.2) years of education) There are multiple parallel versions of the MoCA, an advantage when it might be used more than once with a partient.ĭo you see an error or have a suggestion for this instrument summary? Please e-mail us! The MoCA has a greater emphasis on attention and executive function than the MMSE that is commonly used to screen for cognitive impairments.įor those with mild deficits, the MoCA appears to be more sensitive for those with high premorbid IQ, non-AD dementia and early stages of dementia. This review is not exhaustive, but focused on initial development of the measure and its use with persons with stroke to determine possible appropriateness of the measure for use with TBI. The MoCA has been extensively used and studied in older adult populations and in PD where cognitive impairment is problematic.

Chou et al, 2010 reported task force recommendation (based on review of 353 published articles) was to use MoCA over several other cognitive assessment screens (MMSE, MMP, PANDA, and SCOPA-cog) for detection of MCI in those with PD when cognition is not a primary outcome measure.

Is additional research warranted for this tool (Y/N) Students should be exposed to tool? (Y/N)Īppropriate for use in intervention research studies? (Y/N) Students should learn to administer this tool? (Y/N)

Recommendations for entry-level physical therapy education and use in research: Recommendations for use based on ambulatory status after brain injury: Recommendations based on level of care in which the assessment is taken: Recommendations Based on Parkinson Disease Hoehn and Yahr stage: Reasonable to use, but limited study in target group / Unable to Recommend These recommendations were developed by a panel of research and clinical experts using a modified Delphi process.įor detailed information about how recommendations were made, please visit: 1996 9:50-3.Recommendations for use of the instrument from the Neurology Section of the American Physical Therapy Association’s Multiple Sclerosis Taskforce (MSEDGE), Parkinson’s Taskforce (PD EDGE), Spinal Cord Injury Taskforce (PD EDGE), Stroke Taskforce (StrokEDGE), Traumatic Brain Injury Taskforce (TBI EDGE), and Vestibular Taskforce (Vestibular EDGE) are listed below. Clinical validation of the oral trail making test. Trail making test A improves performance characteristics of the international HIV-dementia scale to identify symptomatic HAND. doi:10.1093/ageing/aft073Ĭhalermchai T, Valcour V, Sithinamsuwan P. doi:10.1016/j.acn.2007.11.005ĭobbs BM, Shergill SS, How effective is the trail making test (parts A and B) in identifying cognitively impaired drivers? Age Ageing.

Trail making test errors in normal aging, mild cognitive impairment, and dementia. Jefferson AL, O'Connor MK, Chaisson C, Green RC, Stern RA. Lowering the Floor on Trail Making Test Part B: Psychometric Evidence for a New Scoring Metric. Trail Making Test: regression-based norms for the Portuguese population. What is dementia? Symptoms, types, and diagnosis.Ĭavaco S, Goncalves A, Pinto C, et al. Llinàs-Reglà J., Vilalta-Franch J, López-Pousa S, Calvó-Perxas L, Torrents Rodas D, Garre-Olmo J.

Moca test instructions scoring